163 related articles for article (PubMed ID: 2144158)
1. Genetic toxicology of tricyclic carboxamides, a new class of DNA binding antitumour agent.
Ferguson LR; Hill CM; Baguley BC
Eur J Cancer; 1990; 26(6):709-14. PubMed ID: 2144158
[TBL] [Abstract][Full Text] [Related]
2. Mutagenicity profiles of newer amsacrine analogues with activity against solid tumours: comparison of microbial and mammalian systems.
Ferguson LR; van Zijl P; Baguley BC
Eur J Cancer Clin Oncol; 1989 Feb; 25(2):255-61. PubMed ID: 2649376
[TBL] [Abstract][Full Text] [Related]
3. Photo-enhancement of the mutagenicity of 9-anilinoacridine derivatives related to the antitumour agent amsacrine.
Iwamoto Y; Ferguson LR; Pearson A; Baguley BC
Mutat Res; 1992 Jul; 268(1):35-41. PubMed ID: 1378184
[TBL] [Abstract][Full Text] [Related]
4. Comparison of the mutagenic and clastogenic activity of amsacrine and other DNA-intercalating drugs in cultured V79 Chinese hamster cells.
Wilson WR; Harris NM; Ferguson LR
Cancer Res; 1984 Oct; 44(10):4420-31. PubMed ID: 6547875
[TBL] [Abstract][Full Text] [Related]
5. Inverse correlation between bacterial frameshift mutagenicity and yeast mitochondrial effects of antitumour anilinoacridines.
Baguley BC; Ferguson LR
Chem Biol Interact; 1985 Dec; 56(2-3):145-55. PubMed ID: 3907865
[TBL] [Abstract][Full Text] [Related]
6. Mutagenicity of selected functionalized benz(c)acridines and a benz(a)phenazine in the Salmonella typhimurium/microsome assay.
Walker BA; Rogan EG; Cromwell NH
Anticancer Res; 1984; 4(6):399-402. PubMed ID: 6393860
[TBL] [Abstract][Full Text] [Related]
7. Comparison of the mutagenicity of amsacrine with that of a new clinical analogue, CI-921.
Ferguson LR; van Zijl P; Baguley BC
Mutat Res; 1988 Feb; 204(2):207-17. PubMed ID: 3278212
[TBL] [Abstract][Full Text] [Related]
8. Mutagenic and clastogenic activity of nitracrine analogues in cultured V79 Chinese hamster cells.
Ferguson LR; van Zijl P
Mutat Res; 1988 Apr; 204(4):655-63. PubMed ID: 3352647
[TBL] [Abstract][Full Text] [Related]
9. Bacterial and mammalian cell mutagenesis, sister-chromatid exchange, and mouse lung adenoma bioassay with the antineoplastic acridine derivative amsacrine.
de la Iglesia FA; Fitzgerald JE; McGuire EJ; Kim SN; Heifetz CL; Stoner GD
J Toxicol Environ Health; 1984; 14(5-6):667-81. PubMed ID: 6394768
[TBL] [Abstract][Full Text] [Related]
10. Cell line selectivity and DNA breakage properties of the antitumour agent N-[2-(dimethylamino)ethyl]acridine-4-carboxamide: role of DNA topoisomerase II.
Schneider E; Darkin SJ; Lawson PA; Ching LM; Ralph RK; Baguley BC
Eur J Cancer Clin Oncol; 1988 Nov; 24(11):1783-90. PubMed ID: 2850193
[TBL] [Abstract][Full Text] [Related]
11. Frameshift mutagenesis by 9-aminoacridine, ICR191, AMSA and related experimental antitumour acridines in recA+ and recA1 strains of Salmonella typhimurium.
Ferguson LR; MacPhee DG
Mutat Res; 1983 Mar; 116(3-4):289-96. PubMed ID: 6339895
[No Abstract] [Full Text] [Related]
12. The mutagenic effects of diacridines and diquinolines in microbial systems.
Ferguson LR; Turner PM; Denny WA
Mutat Res; 1990 Oct; 232(2):337-43. PubMed ID: 2215541
[TBL] [Abstract][Full Text] [Related]
13. Further examination of the effects of nitrosylation on Alternaria alternata mycotoxin mutagenicity in vitro.
Schrader TJ; Cherry W; Soper K; Langlois I
Mutat Res; 2006 Jul; 606(1-2):61-71. PubMed ID: 16698312
[TBL] [Abstract][Full Text] [Related]
14. Microbial mutagenic effects of the DNA minor groove binder pibenzimol (Hoechst 33258) and a series of mustard analogues.
Ferguson LR; Denny WA
Mutat Res; 1995 Jun; 329(1):19-27. PubMed ID: 7539521
[TBL] [Abstract][Full Text] [Related]
15. The genetic toxicology of acridines.
Ferguson LR; Denny WA
Mutat Res; 1991 Sep; 258(2):123-60. PubMed ID: 1881402
[TBL] [Abstract][Full Text] [Related]
16. Unusual dynamics of killing of cultured Lewis lung cells by the DNA-intercalating antitumour agent N-[2-(dimethylamino)ethyl]acridine-4-carboxamide.
Haldane A; Finlay GJ; Gavin JB; Baguley BC
Cancer Chemother Pharmacol; 1992; 29(6):475-9. PubMed ID: 1568291
[TBL] [Abstract][Full Text] [Related]
17. The relationship between frameshift mutagenicity and DNA-binding affinity in a series of acridine-substituted derivatives of the experimental antitumour drug 4'-(9-acridinylamino)methanesulphonanilide (AMSA).
Ferguson LR; Baguley BC
Mutat Res; 1981 Jun; 82(1):31-9. PubMed ID: 7022171
[TBL] [Abstract][Full Text] [Related]
18. Selectivity of N-[2-(dimethylamino)ethyl]acridine-4-carboxamide towards Lewis lung carcinoma and human tumour cell lines in vitro.
Finlay GJ; Baguley BC
Eur J Cancer Clin Oncol; 1989 Feb; 25(2):271-7. PubMed ID: 2702982
[TBL] [Abstract][Full Text] [Related]
19. Induction of mitotic crossing-over by the topoisomerase II poison DACA (N-[2-dimethylamino)ethyl]acridine-4-carboxamide) in Saccharomyces cerevisiae.
Ferguson LR; Turner PM; Baguley BC
Mutat Res; 1993 Oct; 289(2):157-63. PubMed ID: 7690883
[TBL] [Abstract][Full Text] [Related]
20. Mutagenic activities of azido analogues of amsacrine and other 9-anilinoacridines in Salmonella typhimurium and their enhancement by photoirradiation.
Iwamoto Y; Ferguson LR; Pogai HB; Uzuhashi T; Kurita A; Yangihara Y; Denny WA
Mutat Res; 1992 Oct; 280(4):233-44. PubMed ID: 1382224
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]